Pediatric Wilson's Disease: Phenotypic, ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Pediatric Wilson's Disease: Phenotypic, Genetic Characterization and Outcome of 182 Children in France.
Auteur(s) :
Couchonnal, Eduardo [Auteur]
Hôpital Femme Mère Enfant [CHU - HCL] [HFME]
Lion-François, L. [Auteur]
Guillaud, O. [Auteur]
Habes, Dalila [Auteur]
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
Debray, Dominique [Auteur]
Hôpital Necker - Enfants Malades [AP-HP]
Lamireau, Thierry [Auteur]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Broué, Pierre [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Fabre, Alexandre [Auteur]
Hôpital de la Timone [CHU - APHM] [TIMONE]
Marseille medical genetics - Centre de génétique médicale de Marseille [MMG]
Vanlemmens, Claire [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Sobesky, Rodolphe [Auteur]
Centre Hépato-Biliaire [Hôpital Paul Brousse] [CHB]
Gottrand, fréderic [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Bridoux-Henno, Laure [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Dumortier, Jérôme [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Belmalih, A. [Auteur]
Poujois, A. [Auteur]
Jacquemin, Emmanuel [Auteur]
Physiopathogénèse et Traitement des Maladies du Foie [HEPAREG]
Brunet, A. S. [Auteur]
Bost, M. [Auteur]
Lachaux, A. [Auteur]
Hôpital Femme Mère Enfant [CHU - HCL] [HFME]
Lion-François, L. [Auteur]
Guillaud, O. [Auteur]
Habes, Dalila [Auteur]
Hôpital Bicêtre [AP-HP, Le Kremlin-Bicêtre]
Debray, Dominique [Auteur]
Hôpital Necker - Enfants Malades [AP-HP]
Lamireau, Thierry [Auteur]
Centre Hospitalier Universitaire de Bordeaux [CHU Bordeaux]
Broué, Pierre [Auteur]
Centre Hospitalier Universitaire de Toulouse [CHU Toulouse]
Fabre, Alexandre [Auteur]
Hôpital de la Timone [CHU - APHM] [TIMONE]
Marseille medical genetics - Centre de génétique médicale de Marseille [MMG]
Vanlemmens, Claire [Auteur]
Centre Hospitalier Régional Universitaire de Besançon [CHRU Besançon]
Sobesky, Rodolphe [Auteur]
Centre Hépato-Biliaire [Hôpital Paul Brousse] [CHB]
Gottrand, fréderic [Auteur]
Institute for Translational Research in Inflammation - U 1286 [INFINITE]
Bridoux-Henno, Laure [Auteur]
Centre Hospitalier Universitaire de Rennes [CHU Rennes] = Rennes University Hospital [Pontchaillou]
Dumortier, Jérôme [Auteur]
Hôpital Edouard Herriot [CHU - HCL]
Belmalih, A. [Auteur]
Poujois, A. [Auteur]
Jacquemin, Emmanuel [Auteur]
Physiopathogénèse et Traitement des Maladies du Foie [HEPAREG]
Brunet, A. S. [Auteur]
Bost, M. [Auteur]
Lachaux, A. [Auteur]
Titre de la revue :
Journal of Pediatric Gastroenterology and Nutrition
Nom court de la revue :
J Pediatr Gastroenterol Nutr
Date de publication :
2021-06-08
ISSN :
1536-4801
Mot(s)-clé(s) en anglais :
copper
liver transplantation
Wilson disease
liver transplantation
Wilson disease
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Objectives:
To describe a cohort of Wilson disease (WD) pediatric cases, and to point out the diagnostic particularities of this age group and the long-term outcome.
Methods:
Clinical data of 182 pediatric patients ...
Lire la suite >Objectives: To describe a cohort of Wilson disease (WD) pediatric cases, and to point out the diagnostic particularities of this age group and the long-term outcome. Methods: Clinical data of 182 pediatric patients included in the French WD national registry from 01/03/1995 to 01/06/2019 were gathered. Results: Diagnosis of WD was made at a mean age of 10.7 ± 4.2 years (range 1–18 years). At diagnosis, 154 patients (84.6%) had hepatic manifestations, 19 (10.4%) had neurological manifestations, and 9 patients (4.9%) were asymptomatic. The p.His1069Gln mutation was the most frequently encountered (14% of patients). Neurological patients were diagnosed at least 1 year after they presented their first symptoms. At diagnosis, the median urinary copper excretion (UCE) was 4.2 μmol/24 hours (0.2–253). The first-line treatment was d-penicillamine (DP) for 131 (72%) patients, zinc salts for 24 (13%) patients, and Trientine for 17 (9%) patients. Liver transplantation was performed in 39 (21.4%) patients, for hepatic indications in 33 of 39 patients or for neurological deterioration in 6 of 39 patients, mean Unified Wilson's Disease Rating Scale of the latter went from 90 ± 23.1 before liver transplantation (LT) to 26.8 ± 14.1 (P < 0.01) after a mean follow-up of 4.3 ± 2.5 years. Overall survival rate at 20 years of follow-up was 98%, patient and transplant-free combined survival was 84% at 20 years. Conclusion: Diagnosis of WD can be challenging in children, particularly at the early stages of liver disease and in case of neurological presentation; hence the support of clinical scores and genetic testing is essential. Diagnosis at early stages and proper treatment ensure excellent outcomes, subject to good long-term treatment compliance. LT is a valid option for end-stage liver disease not responding to treatment and can be discussed for selected cases of neurological deterioration.Lire moins >
Lire la suite >Objectives: To describe a cohort of Wilson disease (WD) pediatric cases, and to point out the diagnostic particularities of this age group and the long-term outcome. Methods: Clinical data of 182 pediatric patients included in the French WD national registry from 01/03/1995 to 01/06/2019 were gathered. Results: Diagnosis of WD was made at a mean age of 10.7 ± 4.2 years (range 1–18 years). At diagnosis, 154 patients (84.6%) had hepatic manifestations, 19 (10.4%) had neurological manifestations, and 9 patients (4.9%) were asymptomatic. The p.His1069Gln mutation was the most frequently encountered (14% of patients). Neurological patients were diagnosed at least 1 year after they presented their first symptoms. At diagnosis, the median urinary copper excretion (UCE) was 4.2 μmol/24 hours (0.2–253). The first-line treatment was d-penicillamine (DP) for 131 (72%) patients, zinc salts for 24 (13%) patients, and Trientine for 17 (9%) patients. Liver transplantation was performed in 39 (21.4%) patients, for hepatic indications in 33 of 39 patients or for neurological deterioration in 6 of 39 patients, mean Unified Wilson's Disease Rating Scale of the latter went from 90 ± 23.1 before liver transplantation (LT) to 26.8 ± 14.1 (P < 0.01) after a mean follow-up of 4.3 ± 2.5 years. Overall survival rate at 20 years of follow-up was 98%, patient and transplant-free combined survival was 84% at 20 years. Conclusion: Diagnosis of WD can be challenging in children, particularly at the early stages of liver disease and in case of neurological presentation; hence the support of clinical scores and genetic testing is essential. Diagnosis at early stages and proper treatment ensure excellent outcomes, subject to good long-term treatment compliance. LT is a valid option for end-stage liver disease not responding to treatment and can be discussed for selected cases of neurological deterioration.Lire moins >
Langue :
Anglais
Comité de lecture :
Oui
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
Inserm
CHU Lille
Inserm
CHU Lille
Date de dépôt :
2024-01-12T06:48:06Z
2024-02-28T14:45:05Z
2024-02-28T14:45:05Z
Fichiers
- pediatric_wilson_s_disease__phenotypic,_genetic.8.pdf
- Version éditeur
- Accès libre
- Accéder au document